Download PDF
Endoscopy 2005; 37(2): 139-145
DOI: 10.1055/s-2004-826146
State of the Art Review
© Georg Thieme Verlag KG Stuttgart · New York

Therapeutic Biliary Endoscopy

E.  L.  Fogel1 , L.  McHenry1 , S.  Sherman1 , J.  L.  Watkins1 , G.  A.  Lehman1
  • 1Indiana University Medical Center, Indianapolis, Indiana, USA
Further Information

Publication History

Publication Date:
03 February 2005 (online)

Also available at
    Permissions and Reprints

Some steps of progress have been seen in the area of biliary therapeutic endoscopy, in the understanding and management of primary sclerosing cholangitis, problems relating to liver transplantation, malignant biliary strictures, and complications after endoscopic retrograde cholangiopancreatography, as well as sphincter of Oddi dysfunction. These topics are reviewed here.

References

  • 1 Ginsberg G, Cope C, Shah J. et al . In vivo evaluation of a new bioabsorbable self-expanding biliary stent.  Gastrointest Endosc. 2003;  58 777-784
    CrossrefPubMedGoogle Scholar
  • 2 Van Berkel A M, Cahen D L, van Westerloo D J. et al . Self-expanding metal stents in benign biliary strictures due to chronic pancreatitis.  Endoscopy. 2004;  36 381-384
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Cantu P, Morales A, Le Moine O, Devière J. Partially covered metal stenting in patients with symptomatic common bile duct stenosis secondary to chronic pancreatitis: a pilot study [abstract].  Gastrointest Endosc. 2004;  59 AB190
    PubMedGoogle Scholar
  • 4 Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis.  Am J Gastroenterol. 2004;  99 509-510
    CrossrefPubMedGoogle Scholar
  • 5 Vuddagiri S K, France R, Kozarek R. Endoscopic therapy in primary sclerosing cholangitis (PSC): does the complication risk outweigh therapeutic benefit? [abstract].  Gastrointest Endosc. 2004;  59 AB193
    PubMedGoogle Scholar
  • 6 Hisatsune H, Yazumi S, Egawa H. et al . Endoscopic management of biliary strictures after duct-to-duct biliary reconstruction in right-lobe living-donor liver transplantation.  Transplantation. 2003;  76 810-815
    PubMedGoogle Scholar
  • 7 Shah J N, Ahmad N A, Shetty K. et al . The bile duct: the Achilles’ heel of living donor liver transplantation.  Am J Gastroenterol. 2004;  99 1296-1297
    CrossrefPubMedGoogle Scholar
  • 8 Morelli J, Mulcahy H E, Willner I R. et al . Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement.  Gastrointest Endosc. 2003;  58 374-379
    CrossrefPubMedGoogle Scholar
  • 9 Brodsky J A, Marks J M, Maim J A . al. Sphincter of Oddi injection with botulinum toxin is as effective as endobiliary stent in resolving cystic duct leaks in a canine model.  Gastrointest Endosc. 2002;  56 849-851
    CrossrefPubMedGoogle Scholar
  • 10 Bhattacharjya S, Puleston J, Davidson R R. et al . Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection.  Gastrointest Endosc. 2003;  57 526-530
    CrossrefPubMedGoogle Scholar
  • 11 Reed D N , Vitale G C, Wrightson W R. et al . Decreasing mortality of bile leaks after elective hepatic surgery.  Am J Surg. 2003;  1854 316-318
    PubMedGoogle Scholar
  • 12 Seewald S, Groth S, Sriram P V. et al . Endoscopic treatment of biliary leakage with N-butyl-2 cyanoacrylate.  Gastrointest Endosc. 2002;  56 916-919
    CrossrefPubMedGoogle Scholar
  • 13 Freeman M L, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.  Gastrointest Endosc. 2003;  58 41-49
    CrossrefPubMedGoogle Scholar
  • 14 de Palma G D, Pezzullo A, Rega M. et al . Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study.  Gastrointest Endosc. 2003;  58 50-53
    CrossrefPubMedGoogle Scholar
  • 15 Isayama H, Komatsu Y, Tsujino T. et al . A prospective randomised study of ”covered” versus ”uncovered” diamond stents for the management of distal malignant biliary obstruction.  Gut. 2004;  52 729-734
    PubMedGoogle Scholar
  • 16 van Berkel A M, Bruno M J, Bergman J JGHM. et al . A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction.  Endoscopy. 2003;  35 478-482
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Ortner M EJ, Caca K, Berr F. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.  Gastroenterology. 2003;  125 1355-1363
    CrossrefPubMedGoogle Scholar
  • 18 Masci E, Mariani A, Curioni S, Testoni P A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.  Endoscopy. 2003;  35 830-834
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Freeman M L, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.  Gastrointest Endosc. 2004;  59 8-14
    CrossrefPubMedGoogle Scholar
  • 20 Sherman S, Blaut U, Watkins J L. et al . Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis? A randomized, prospective, multicenter study.  Gastrointest Endosc. 2003;  58 23-29
    CrossrefPubMedGoogle Scholar
  • 21 Poon R T, Yeung C, Liu C L. et al . Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomized controlled trial.  Gut. 2003;  52 1768-1773
    CrossrefPubMedGoogle Scholar
  • 22 Murray B, Carter R, Imrie C. et al . Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.  Gastroenterology. 2003;  124 1786-1791
    CrossrefPubMedGoogle Scholar
  • 23 Masci E, Cavallini G, Mariani A. et al . Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.  Am J Gastroenterol. 2003;  35 2182-2186
    PubMedGoogle Scholar
  • 24 Bertalan V, Madacsy L, Pavics L. et al . Scintigraphic sign of functional biliary obstruction is pathognomic for sphincter of Oddi dysfunction.  Hepatogastroenterology. 2004;  51 76-81
    PubMedGoogle Scholar
  • 25 Mariani A, Curioni S, Zanello A. et al . Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis.  Gastrointest Endosc. 2003;  58 847-852
    CrossrefPubMedGoogle Scholar
  • 26 Agrawal D, Singh P, Das A. et al . Efficacy of manometry based endoscopic sphincterotomy in sphincter of Oddi dysfunction: a meta-analysis of controlled trials [abstract].  Am J Gastroenterol. 2003;  98 S70
    PubMedGoogle Scholar
  • 27 Park S H, Watkins J L, Fogel E L. et al . Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.  Gastrointest Endosc. 2003;  57 483-491
    CrossrefPubMedGoogle Scholar
  • 28 Arguedas M R, Linder J D, Wilcox C M. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?.  Endoscopy. 2004;  36 174-178
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Wehrmann T. Sphincter of Oddi dysfunction: cut and inject, but don’t measure the pressure? [editorial].  Endoscopy. 2004;  36 179-182
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Gorelick A, Barnett J, Chey W. et al . Botulinum toxin injection after biliary sphincterotomy.  Endoscopy. 2004;  36 170-173
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Hui C K, Lai K C, Yuen M F. et al . The role of cholecystectomy in reducing recurrent gallstone pancreatitis.  Endoscopy. 2004;  36 206-211
    Article in Thieme ConnectPubMedGoogle Scholar

Glen A. Lehman, M. D.

Indiana University Medical Center

550 N. University Boulevard, Suite 4100 · Indianapolis, IN 46202 · USA

Fax: +1-317-278-0164

Email: glehman@iupui.edu

      >